XRAY - Dentsply upgraded at William Blair after earnings pre-announcement

• William Blair Upgraded Dentsply Sirona ( NASDAQ: XRAY ) to Market Perform from Underperform after the dental product maker issued its preliminary 2022 financials on Wednesday, which according to the firm, slightly beat high-end of sales guidance and met the adj. EPS guidance.
• “This was a welcomed preannouncement that shows, in our view, a stabilizing organization after several quarters of declining EPS expectations,” the analyst Brandon Vazquez and the team wrote.
• The analysts cited management comments to argue that the company is looking to reach $3.00 earnings per share by 2025, which suggests plans for a double-digit EPS CAGR after addressing near-term headwinds and introducing new strategies.
• The team also notes that Dentsply ( XRAY ) has resolved four issues that led to their previous downgrade, including the leadership uncertainty and overhang from an accounting investigation.
• Issuing a Sell rating on Dentsply ( XRAY ) in December, Seeking Alpha contributor Mike Zaccardi noted higher risks to the company than prospects for its upside potential.

For further details see: